ÂÜÀòÂÒÂ×

Brian Wiley has over 25 years of experience in the pharmaceutical and biotechnology market, covering all aspects of corporate strategy, business development, and commercialization, including overall corporate strategy, licensing, collaborations, and M&A transactions, financings, as well as multiple product launches and commercial infrastructure creation. Brian is currently serving as Principal & Founder at Boston BioConsulting, LLC, where they provide services of commercialization strategy and business development to clients in the pharmaceutical and biotechnology market. Brian is also currently serving as the Chief Business Officer at Portage Biotech Inc and as a Senior Vice President of Corporate Development at ENA Respiratory Pty Ltd. In 2023, they will be joining Provenance Bio as Head of Business Development and The Sage Group Inc as Executive Director. Brian also has experience as Interim Head of Business Development at Kenjockety Biotechnology, Inc., where they were responsible for developing an extensive pipeline of multi-modal bispecific antibody (BsAb) therapeutics for patients with cancer. Brian has also worked as a Strategic Advisor at BlueAllele and as Chief Commercial Officer and Head of Business Development at NewLink Genetics. Additionally, they served as Senior Director, Oncology Marketing at Celgene.

Brian Wiley attended The Pennsylvania State University from 1985 to 1990, where they obtained a Bachelor's degree in Marketing.